ES526641A0 - Un procedimiento para preparar derivados de aminonaftaceno - Google Patents

Un procedimiento para preparar derivados de aminonaftaceno

Info

Publication number
ES526641A0
ES526641A0 ES526641A ES526641A ES526641A0 ES 526641 A0 ES526641 A0 ES 526641A0 ES 526641 A ES526641 A ES 526641A ES 526641 A ES526641 A ES 526641A ES 526641 A0 ES526641 A0 ES 526641A0
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
aminonaphthene
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526641A
Other languages
English (en)
Other versions
ES8602836A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of ES8602836A1 publication Critical patent/ES8602836A1/es
Publication of ES526641A0 publication Critical patent/ES526641A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES526641A 1982-10-22 1983-10-21 Un procedimiento para preparar derivados de aminonaftaceno Granted ES526641A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57186514A JPS5976099A (ja) 1982-10-22 1982-10-22 アミノナフタセン誘導体とその製造方法

Publications (2)

Publication Number Publication Date
ES8602836A1 ES8602836A1 (es) 1985-11-01
ES526641A0 true ES526641A0 (es) 1985-11-01

Family

ID=16189827

Family Applications (2)

Application Number Title Priority Date Filing Date
ES526641A Granted ES526641A0 (es) 1982-10-22 1983-10-21 Un procedimiento para preparar derivados de aminonaftaceno
ES543672A Granted ES543672A0 (es) 1982-10-22 1985-05-30 Un procedimiento para preparar derivados de 9-aminonaftaceno

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543672A Granted ES543672A0 (es) 1982-10-22 1985-05-30 Un procedimiento para preparar derivados de 9-aminonaftaceno

Country Status (7)

Country Link
US (1) US4673668A (es)
EP (1) EP0107486B1 (es)
JP (1) JPS5976099A (es)
AT (1) ATE26839T1 (es)
CA (1) CA1245642A (es)
DE (1) DE3371205D1 (es)
ES (2) ES526641A0 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
US6376469B1 (en) 1997-11-28 2002-04-23 Sumitomo Pharmaceuticals Company, Limited Crystalline amrubicin hydrochloride
EP1364652B1 (en) * 2001-01-30 2014-04-09 Dainippon Sumitomo Pharma Co., Ltd. Remedies for lung cancer
US7091188B2 (en) * 2001-10-23 2006-08-15 Sumitomo Chemical Company, Limited Stabilization of amrubicin hydrochloride
CA2509449C (en) 2002-11-29 2012-01-31 Sumitomo Pharmaceuticals Co., Ltd. Lyophilized preparation of stabilized anthracycline compounds
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
ES2524700T3 (es) 2009-05-27 2014-12-11 Sumitomo Dainippon Pharma Co., Ltd. Formulación estabilizada y liofilizada de compuestos de antraciclina
CL2011000718A1 (es) 2010-03-31 2012-04-09 Gilead Pharmasset Llc Proceso para la preparacion de compuestos fosforados enantiomericos.
CN103421059B (zh) * 2012-05-22 2016-04-06 重庆圣华曦药业股份有限公司 一种氨柔比星的合成方法
CN105367418A (zh) * 2014-08-14 2016-03-02 上海科胜药物研发有限公司 一种四氢萘类化合物及其合成方法
US10668166B2 (en) 2016-05-30 2020-06-02 Toxinvent Ou Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
IT1098211B (it) * 1978-05-09 1985-09-07 Farmaceutici Italia Deossiantracicline antitumorali
US4540695A (en) 1981-08-12 1985-09-10 Sumitomo Chemical Co., Ltd. Aminonaphthacene derivatives and their use

Also Published As

Publication number Publication date
DE3371205D1 (en) 1987-06-04
US4673668A (en) 1987-06-16
ATE26839T1 (de) 1987-05-15
CA1245642A (en) 1988-11-29
ES8602836A1 (es) 1985-11-01
EP0107486A1 (en) 1984-05-02
JPS5976099A (ja) 1984-04-28
EP0107486B1 (en) 1987-04-29
ES8603858A1 (es) 1986-01-01
ES543672A0 (es) 1986-01-01

Similar Documents

Publication Publication Date Title
ES467961A1 (es) Procedimiento para preparar derivados de calconas
ES543672A0 (es) Un procedimiento para preparar derivados de 9-aminonaftaceno
PT83843B (pt) Processo para a preparacao de promedicamentos de rapamicina
DK145627C (da) Analogifremgangsmaade til fremstilling af 9-substituerede hypoxanthinderivater
ES506660A0 (es) Procedimiento de preparacion de nuevos derivados de benzol-y &-hidroxibencilpenil-osidos.
SE7712861L (sv) Antracyklinderivat och forfarande for framstellning derav
ES488446A1 (es) Procedimiento para la preparacion de nuevos derivados indo- licos
ES555007A0 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
AU536912B2 (en) Benzothiazole derivatives
SE8703999D0 (sv) Antracyklinglykosider med antitumor effekt, framstellning, mellanprodukter, kompositioner och anordning
NO154391C (no) E 2-amino-naftalen-derivater.
IT1131887B (it) Glicosidi antraciclinici
ES454823A1 (es) Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina.
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
ES505896A0 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
ES505328A0 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
GB1453394A (en) Phenylpropylamine derivatives
ZA8312B (en) Substituted 1-benzoyl-2-phenyliminiomidazolidine derivatives
SE8302084D0 (sv) New benzimidazole derivatives
ES501137A0 (es) Un procedimiento de preparacion de derivados de tiazol
SE8004622L (sv) Acylaminobensoesyraderivat
GB1545077A (en) Process for purifying water using bis-isothiouronium salts
ES316741A1 (es) Procedimiento para la obtencion de derivados de la 5,6,7,9, 10,14b-hexahidro-isoquinolo-(2,1-d) benzo (1,4)-diacepin-6ona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050613